Offerings // Vanda Pharmaceuticals Inc.

VNDA offering history

Every offering-related filing in Vanda Pharmaceuticals Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 1,004 filings back to May 27, 2009.

Last executed offering

Mar 16, 2018

424B5 — priced deal (shares or notes)

Last registration (announced)

Feb 12, 2026

S-3 — capacity, not a sale

Executed, last 12 months

424B pricings + 8-K 3.02 sales

Registered, last 12 months

S-1/S-3/F-series registrations

Date	Filing		What it means
May 5, 2026	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Feb 12, 2026	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
May 5, 2023	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
May 3, 2023	S-3/A →	REGISTERED	S-3/A registration — capacity to sell shares, not a sale yet
Feb 9, 2023	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Mar 16, 2018	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Mar 14, 2018	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jul 21, 2015	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Jul 6, 2015	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Dec 22, 2014	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Oct 29, 2014	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Oct 28, 2014	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Oct 4, 2013	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Sep 27, 2013	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Aug 7, 2013	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Aug 6, 2013	S-3MEF →	REGISTERED	S-3MEF registration — capacity to sell shares, not a sale yet
Aug 6, 2013	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Feb 11, 2011	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Jan 31, 2011	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet

VNDA offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full VNDA workspace →

VNDA offering FAQ

When did VNDA last execute an offering?

Per SEC filings, Vanda Pharmaceuticals Inc.'s most recent priced offering document is a 424B5 filed 2018-03-16. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did VNDA last announce or register an offering?

The most recent registration is a S-3 filed 2026-02-12. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.